Intrauterine Devices Market Forecast 2035: Growing Focus on Long-acting Contraceptives and Technological Innovations Boost Market Demand | Transparency Market Research, Inc

The global intrauterine devices (IUDs) market is on a robust growth trajectory. Valued at US$ 4.7 billion in 2024, it is forecast to expand at a healthy CAGR of 10.6% between 2025 and 2035, ultimately crossing US$ 14.2 billion by the end of 2035. This strong performance reflects the market's evolution as demand for safe, long-acting, and reversible contraceptives rises worldwide. Key factors such as increased awareness, supportive government initiatives, and continuous innovation in product design are shaping this dynamic growth story.

Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86611

Market Overview: The Growing Popularity of IUDs

Intrauterine devices are T-shaped contraceptive devices placed inside the uterus by a trained healthcare professional. These devices offer long-term protection ranging from 3 to 10 years, depending on the type:

Copper IUDs, which are hormone-free and prevent pregnancy by releasing copper ions toxic to sperm.

Hormonal (levonorgestrel) IUDs, which gradually release hormones to thicken cervical mucus, inhibit sperm movement, and reduce menstrual symptoms.

Unlike daily pills or short-acting methods, IUDs require minimal ongoing maintenance, making them highly appealing for women seeking a "fit-and-forget" solution. This appeal, paired with evidence-backed efficacy rates over 99%, has positioned IUDs as a cornerstone of modern contraceptive strategies.

Public health campaigns, rising consumer literacy, and proactive counseling by healthcare professionals have further accelerated adoption, spanning urban centers and extending into rural areas.

Market Drivers: Why Demand Is Rising

Increasing Awareness Among Women

Over the past decade, public health initiatives, NGOs, and digital platforms have amplified awareness about IUDs, their safety, and their non-contraceptive health benefits. Women are now better informed about:

High efficacy and reversibility

Reduced risk of user error compared to daily pills

Added benefits like decreased menstrual pain and lighter periods (for hormonal IUDs)

As women increasingly prioritize autonomy and convenience in reproductive health, IUDs have become a preferred option, especially among the 21-34 age group, which accounts for a substantial market share.

Government-Led Family Planning Initiatives

Governments across regions, from North America to Asia and Africa, are actively promoting long-acting reversible contraceptives (LARCs) like IUDs to reduce unintended pregnancies and improve maternal health outcomes. Policies such as:

Insurance coverage under the Affordable Care Act (U.S.)

Subsidized distribution through public hospitals and health centers

Collaboration with organizations like UNFPA and WHO

These programs ensure equitable access, especially in rural and underserved communities, significantly boosting market penetration.

Product Innovation Enhancing Safety and Comfort

Technological advancements have transformed IUD design and materials. New features include:

Shape-memory alloys, minimizing malposition risk

Flexible and smaller insertors for more comfortable placement

Low-dose copper IUDs to reduce side effects while maintaining efficacy

For instance, Sebela Pharmaceuticals' investigational Copper 175 mm2 IUD reported a 99.0% efficacy rate over three years in Phase 3 trials. Similarly, 49Care's Yanae IUD, launched in Canada in January 2025, features a flexible insertor designed to ease the insertion process, reflecting a broader trend toward patient-centered design.

Segmentation Analysis: Key Market Insights

By Product Type: Hormonal IUDs Dominate

Hormonal IUDs have emerged as the most popular choice among women. Beyond contraception, they help:

Reduce menstrual bleeding and pain

Manage conditions like endometriosis or heavy menstrual bleeding

Their dual function and longer protection period (up to 7 years) explain why healthcare providers increasingly recommend hormonal IUDs, fueling their dominant market share.

By Age Group: Strong Demand Among 21-34

The 21-34 demographic leads in adoption, as many women in this age group are balancing career, education, and family planning. The flexibility to delay pregnancy without compromising future fertility is a key advantage driving adoption.

By End-user: Hospitals and Gynecology Clinics Lead

Due to the need for professional insertion and follow-up, hospitals and gynecology clinics remain the primary distribution channels. Community health centers are critical for expanding access, especially under government-led outreach and rural health programs.

Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/intrauterine-devices-market.html

Regional Outlook: North America Leads, Emerging Markets Rising

🇺🇸 North America

The North American market, especially the U.S., is the largest regional segment. Factors contributing to leadership include:

Broad insurance coverage for contraceptives

Strong consumer awareness

Availability of advanced products and robust healthcare infrastructure

Programs like Title X have improved affordability and access, making IUDs a mainstream option.

Asia Pacific & Latin America

Emerging markets show promising growth fueled by:

Rising urbanization and middle-class expansion

Shifts in cultural attitudes toward contraception

Increased government investment in family planning

Companies are targeting these regions through partnerships and localized product launches.

Competitive Landscape: Innovation and Expansion

Leading market players include:

AbbVie

Bayer AG

CooperSurgical Inc

DKT INTERNATIONAL

EUROGINE, S.L.

Mona Lisa N.V.

OCON Medical Ltd

Pregna International Limited

Prosan International BV

SMB Corporation of India

These companies focus on:

Developing next-generation IUDs with improved safety and comfort

Strategic collaborations with hospitals, clinics, and NGOs

Expanding geographically into high-growth regions

Recent developments like Sebela Pharmaceuticals' positive Phase 3 results and 49Care's Yanae launch underscore ongoing innovation in this space.

Want to know more? Get in touch now. -https://www.transparencymarketresearch.com/contact-us.html

Explore Latest Research Reports by Transparency Market Research:

Anal Irrigation Systems Market - https://www.transparencymarketresearch.com/anal-irrigation-systems-market.html

Biologics Market - https://www.transparencymarketresearch.com/global-biologics-market.html

Blood Gas and Electrolyte Analyzers Market - https://www.transparencymarketresearch.com/blood-gas-electrolyte-analyzers-market.html

Indwelling Catheters Market - https://www.transparencymarketresearch.com/indwelling-catheter-market.html

Indirect Calorimeter Market - https://www.transparencymarketresearch.com/indirect-calorimeter-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.